UNSPSC 51152026: Denpidazone

This classification denotes a muscle relaxant with the molecular formula C20H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7N3FX2T1J, chemically known as 3,6-pyridazinedione, 1,2-dihydro-4-butyl-5-hydroxy-1,2-diphenyl- but generally known as denpidazone, which bears US NIH Compound Identifier 206004. European Medicines Agency schedules Denpidazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06979MIG.

UNSPSC 51152026 Denpidazone is a Commodity code that in practice covers naloxone and drug deactivation systems procured by state and local health and safety agencies to support community health and overdose-response initiatives. State and local governments buy these products for public health programs, emergency response, and community harm-reduction efforts. Issuing bodies include county health departments and public health authorities managing opioid-response programs and community health services. The procurement process requires vendors to meet standard compliance standards including drug-free workplace certification, E-Verify authorization, and appropriate insurance coverage for workers' compensation and liability.

Seminole County, Florida, posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. The contract includes a two-year initial term with an option for one-year renewal, and bidders must submit unit costs for each line item with all shipping and delivery costs included in their proposals. The source shows limited recent activity under this code; this single opportunity in Florida represents the available public information on current state and local procurement under UNSPSC 51152026.